Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1997-03-21
1999-11-02
Wax, Robert A.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
435195, 435325, 4352523, 43525233, 4352351, 4353201, 536 231, 536 232, 536 235, C12N 916, C07H 2104
Patent
active
059768533
ABSTRACT:
A novel serine/threonine phosphatase, FIN13, which includes a collagen-homology domain, an acidic box domain, a catalytic domain, and a putative nuclear translocation sequence. The present invention further relates to the modulation of cellular proliferation, by regulating the activity of the novel serine/threonine phosphatase. Thus, the invention provides the phosphatase, nucleic acids encoding the phosphatase, oligonucleotides specific for such nucleic acids, antibodies to the phosphatase, and methods for increasing (or decreasing) the activity of the phosphatase to inhibit (or enhance) cellular proliferation and, thus, tissue growth. Various diagnostic and therapeutic aspects of the invention particularly relate to detection and treatment of hyperproliferative disorders, neoplasms, and tumors. In specific examples, FIN13 is expressed in proliferating cells, notably gern cells of the testes. Increased levels of expression of FIN13 in transfected cells results in a decrease in the cell growth rate.
REFERENCES:
Hunter, 1995, Cell, 80:225-236.
Wilson et al., 1994, Nature 368:32-8.
Scherens et al., 1993, Yeast 9:1355-71.
Terasawa et al. 1993 Arch. Biochem. Biophys. 307:342-9.
Basilico and Moscatelli, 1992, Adv. Cancer Res., 59:115-165.
Lanahan et al., 1992, Mol. Cell. Biol., 12:3919-3929.
Mann et al., 1992, Biochem. Biophys. Acta 1130:100-4.
Wenk et al., 1992, FEBS Lett. 297:135-8.
Gomez and Cohen, 1991, Nature, 353:170-173.
Ito et al., 1990, Oncogene, 5:1755-1760.
Lim et al., 1989, Mol. Cell. Biol., 9:1790-1793.
Ryseck, R.P., et al., 1989, Exp. Cell Res., 180:266-275.
Chavrier et al., 1988, EMBO J., 7:29-35.
Lemaire et al., 1988, Proc. Natl. Acad. Sci. U.S.A., 85:4691-4695.
Stein, R., et al., 1988, Deve. Biol., 127:316-325.
Delli Bovi and Basilico, 1987, Proc. Natl. Acad. Sci. USA 84:5660.
Carter, TC, 1951, J. Genet. 50:277-99.
Hillier et al. (1995) EMBL Entry: Accession # R53331.
Wang et al. (1995) J. Biol. Chem. 270:25607-12.
Qin et al. (1996) FASEB J. 10:A1251.
Huang et al. (1996) EMBL Entry: Accession # U81159.
Guthridge et al. (1996) Oncogene 12:1267-78.
Klumpp et al. (1994) J. Biol. Chem. 269:32774-80.
Wenk et al. (1995) Eur. J. Cell Biol. 68:377-86.
Kitamura et al. (1992) Jap. J. Can. Res. 83:66-71.
Mumby et al. (1993) Phys. Rev. 73:673-99.
Peruski, Jr. et al. (1993) Adv. Prot. Phosphatases.
Basilico Claudio
Guthridge Mark A.
Nashed Nashaat T.
New York University Medical Center
Wax Robert A.
LandOfFree
Growth factor inducible serine/threonine phosphatase FIN13 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth factor inducible serine/threonine phosphatase FIN13, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor inducible serine/threonine phosphatase FIN13 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2133619